Page 6 - Data Capture Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

J&J is top machine learning innovator in clinical trial operations in Q1 2022

J&J is top machine learning innovator in clinical trial operations in Q1 2022
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Electronic data capture solutions for clinical trialsData capture solutionsCellular immune

How is fintech innovation progressing in the clinical trial operations industry?

How is fintech innovation progressing in the clinical trial operations industry?
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaCentric services forElectronic data capture solutions for clinical trialsHanmi science co ltdSample servicesUnited bio pharma incPfizer incBridgebio pharma incCentric servicesAlternate site clinical trialsClinical supplyBiological sampleData capture solutions

SK bioscience-GSK s Covid-19 vaccine meets Phase III trial s goals

SK bioscience and GSK have reported that their Covid-19 vaccine candidate, SKYCovione met the coprimary goals in the Phase III clinical trial.

Republic ofNew zealandSouth koreaL vivs ka oblastAstrazeneca covidRoger connorSkycovione covidKorean ministry of foodElectronic data capture solutions for clinical trialsWorld health organizationTime data services for clinical researchKorean ministryDrug safetyData capture solutionsTime data servicesClinical research

CNS to commence trial of Berubicin for glioblastoma multiforme

CNS Pharmaceuticals is set to commence its pivotal trial of Berubicin to treat recurrent glioblastoma multiforme (GBM).

John climacoCentric services forElectronic data capture solutions for clinical trialsCompetent authorityDrug administrationHealth productsChildren memorial health instituteCelm provincial de sevilla ethics committeeCns pharmaceuticalsSpanish agency for medicinesSpanish agencyProvincial de sevilla ethics committeeMemorial health instituteRegulatory consultationData capture solutionsCentric services

Alterity receives MHRA authorisation for Phase II trial of MSA therapy

Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.

United statesNew zealandUnited kingdomDavid stamlerElectronic data capture solutions for clinical trialsEuropean commissionDrug administrationSample servicesRegulatory agencyAlterity therapeuticsMultiple system atrophyUnited kingdom medicinesCellular immuneClinical supplyBiological sampleData capture solutions